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Endovascular aneurysm repair is superior to open
surgery for ruptured abdominal aortic aneurysms
in EVAR-suitable patients
Jan A. Ten Bosch, MD,a Joep A.W. Teijink, MD, PhD,b Edith M. Willigendael, MD, PhD,a and
Martin H. Prins, MD, PhD,c Heerlen, Eindhoven, and Maastricht, The Netherlands
Objective: Efficacy results of endovascular repair (rEVAR) for ruptured abdominal aortic aneurysm (rAAA) compared with
open surgery are based on several observational studies containing selection bias. The present study compared rEVAR with
open surgery in EVAR-suitable patients with an rAAA who all underwent the same preoperative imaging protocol.
Methods: Our policy is to perform a computed tomography angiography on all patients with a suspected rAAA. rEVAR
was performed when the rEVAR-vascular surgeon was on call and the patient was suitable for EVAR. Afterwards, two
experienced independent blinded experts assessed all computed tomography angiography (CTA) scans on EVAR-
suitability. Only EVAR-suitable patients were included in the main analyses. Outcome parameters included mortality
(intraoperative, 30-day, and 6-month), complications, reinterventions, and length of hospital stay.
Results: FromApril 2002 until March 2008, 132 consecutive patients with suspected rAAAs were presented. Preoperative
CTA confirmed rAAA in 104 patients, of whom 25 underwent rEVAR, and 79 underwent open surgery. In retrospect,
the 25 rEVAR patients and 33 patients in the open group were judged EVAR-suitable by the experts. At baseline, there
was an equal distribution of physiologic and anatomic characteristics as well as comorbidity. In EVAR-suitable patients,
the intraoperative, 30-day, and 6-month mortality was 4.0% (1 of 25), 20.0% (5 of 25), and 28.0% (7 of 25) after rEVAR
compared with 6.1% (2 of 33; P >.99), 45.5% (15 of 33; P  .04), and 54.5% (18 of 33; P  .04) after open surgery,
respectively. Median length of hospital stay was 9.5 days (interquartile range, 5.0-20.5) after rEVAR and 17.0 days
(interquartile range, 9.5-28.0) after open surgery (P  .03).
Conclusions: In EVAR-suitable patients, an absolute perioperative mortality reduction of 25.5% of rEVAR over open surgery
was found, whichwas still present at 6months of follow-up. These data suggest that rEVAR is a superior treatment option for
EVAR-suitable patients with an rAAA compared with an open surgery. (J Vasc Surg 2010;52:13-8.)Until 1994, ruptured abdominal aortic aneurysms
(rAAAs) were treated with open surgery, carrying a signif-
icant mortality and morbidity. When an rAAA occurs, 40%
of the patients do not reach the hospital alive.1 In patients
who reach the hospital and undergo conventional open
surgery, the reported 30-day mortality and morbidity rates
are as high as 38% to 49% and 56% to 62%, respectively.2-6
Despite medical and surgical progress, there has been only
a gradual decline in mortality in the past 50 years.3 This
might be due to the combined effects of general anesthesia,
surgical exposure, hemorrhage, and aortic clamping with
lower torso ischemia-reperfusion injury.7
In 1991, Parodi et al8 introduced a minimally invasive
technique for AAA repair. This endovascular aneurysm
repair (EVAR)8 can be performed under local anesthesia
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In the elective setting, EVAR has been associated with
lower 30-day mortality and morbidity rates compared with
open repair.10,11 Since its first description by Yusuf et al12
in 1994, EVAR has successfully been used in feasible pa-
tients to treat rAAA (rEVAR).12
It is still open to debate whether rEVAR will lead to
an important improvement in outcomes compared with
conventional open surgery. Several studies compare early
mortality and morbidity in endovascular repair vs open
repair,13-22 and most of them show a reduction in early
complications and mortality.13-19,21 In acute conditions
like rAAA, truly randomized studies are difficult to per-
form. As a result of lack of randomization, comparative
studies so far are flawed by methodologic inadequacies
such as selection bias, which is created by inadequate
control of potential confounding secondary to inade-
quate patient matching.7 Patients who are selected for
rEVAR constitute a lower-risk category, presumably be-
cause they need to be hemodynamically more stable for
preoperative imaging and have a more favorable ana-
tomic configuration.
The present study eliminated selection bias due to
inadequate patient matching by reporting a comparison of
emergency endovascular repair and open surgery in patients
with an rAAA who all had the same preoperative imaging
protocol, regardless of hemodynamic condition, and who
were all anatomically suitable for EVAR.
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Population and treatment protocol. All patients
presenting with clinically suspected rAAAs at the emer-
gency department of the Atrium Medical Center, Heerlen,
the Netherlands, a nonacademic teaching hospital, received
immediate abdominal ultrasound imaging to look for pres-
ence of an AAA and signs of rupture. Patients with a
suspected rAAA underwent a computed tomography an-
giography (CTA) scan (nonenhanced and arterial phase
acquisition) 30 minutes after presentation to confirm
rupture and to assess EVAR suitability and AAA diameter.
A multidetector 16-slice spiral CT scanner (Somaton Sen-
sation, Siemens, Forccheim, Germany) was used with the
following parameters: high-speedmode capability; rotation
time, 0.5 seconds; table speed, 24 mm/rotation; collima-
tion, 1.5 mm; and slice thickness, 3 mm.
Rupture was defined as extravasation of blood or he-
matoma outside the AAA on CT examination and/or
hematoma outside the AAA during open repair or at au-
topsy. Patients with a CTA-confirmed rAAA were eligible
for the study. The emergency treatment protocol for pa-
tients with an rAAA allows hypotension to a systolic blood
pressure of 70 mm Hg to reduce the risk of ongoing
bleeding, if consciousness is maintained (permissive hypo-
tension).
While the CTA scan was being performed, the vascular
surgeon on call was informed. In the Atrium Medical
Center, we have a mean annual rAAA rate of 22 and three
vascular surgeons (vs), two with experience in open rAAA
repair (non-rEVAR-vs, both 20 years of experience) and
one with experience in both open and endovascular rAAA
repair (rEVAR-vs, 8 years of experience). rEVAR was per-
formed when the rEVAR-vs was on call and determined
that the CTA showed the patient was suitable for EVAR.
Conventional open surgery was performed when the
rEVAR-vs was not on call, regardless of CTA findings (Fig
1). The Institutional Review Board waived the requirement
for informed consent because the analyzed patient data
were documented as part of routine clinical care. Patients’
formal written informed consents were not necessary for
use of their data according to good clinical practice in The
Netherlands.
Definitions. rEVAR was described as the endovascu-
lar repair of a rAAA. Suitability rate for rEVAR was defined
as the percentage of patients with an rAAA evaluated by
CTA scan who were anatomically candidates for rEVAR. A
systolic blood pressure 100 mm Hg was defined as he-
modynamically unstable.
Cardiovascular comorbidity included history of isch-
emic heart disease, cerebrovascular accident or transient
ischemic attack, hypertension, cardiac failure, a coronary
artery bypass graft, percutaneous transluminal coronary
angioplasty, valvular disease, rhythm disorders, and a his-
tory of aortic operation. Pulmonary comorbidity was de-
fined as the presence of at least one of the following:
asthma, chronic obstructive pulmonary disease, emphy-
sema, or lung carcinoma. Renal dysfunction was defined asa serum creatinine level 140 mol/L. Diabetes mellitus
was defined as receiving oral medication or insulin therapy.
Procedure. A fully equipped operating room (OR)
with a mobile C-arm imaging system (Philips Endura,
Philips Medical Systems, Eindhoven, the Netherlands),
trained OR staff with EVAR experience, and two angiog-
raphy assistants are permanently available. Patients with an
rAAA who underwent open repair received general anes-
thesia, whereas patients who underwent endovascular re-
pair preferentially received local anesthesia. Open repair
was performed using the regular inlay technique, replacing
the aneurysm by a bifurcated or tube graft, and leaving the
aneurysmal sac in situ. rEVAR was performed by the rE-
VAR-vs without the aid of an interventional radiologist, by
bilateral groin incision to provide access to the common
femoral artery. In case of aortouniiliac stent grafting, femo-
rofemoral bypass graft surgery was performed under local
anesthesia to restore blood flow to the contralateral leg.
Correct infrarenal placement of the aortouniiliac or aorto-
biiliac endograft was obtained with fluoroscopy and intra-
operative angiography. A control angiography was per-
formed after the procedure was completed.
Since April 2002, a standard emergency set of aortou-
niiliac endografts and distal extender iliac device limbs
(Talent, Medtronic, Santa Rosa, Calif) has been available,
as described previously.19 Since April 2006, a full stock of
bifurcated devices (Talent) has been permanently available
in the OR.
Clinical follow-up and outcomes. Follow-up after
rAAA repair was scheduled at the vascular surgery out-
patient department at 2 weeks, 3 and 12 months, and
yearly thereafter. Follow-up imaging after open rAAA
repair (ultrasound) and rEVAR (multiphasic CTA
imaging—nonenhanced, arterial, and delayed phase
acquisition 70 seconds after intravenous contrast
medium injection) were scheduled at the 3-and 12-
month follow-up visit and yearly thereafter.
At baseline, gender, age, bodymass index, bloodpressure,
mean heart rate, serum creatinine levels, and comorbidity
were recorded. The outcomes evaluated were mortality (in-
traoperative, 30-day, and 6-month) and all complications,
reinterventions, and hospital length of stay. Complications
were classified as deployment or procedure-related, implant-
related, and systemic according to Reporting Standards for
Endovascular Aortic Aneurysm Repair.23
CTA evaluation for EVAR suitability. Two inde-
pendent experienced external experts (product specialists of
Medtronic), blinded for earlier evaluation and intervention
as well as outcome, assessed all preoperative CTA scans for
EVAR suitability. In case of disagreement between the
experts, consensus was found in collaboration with an
arbiter who was also blinded for earlier evaluation, inter-
vention, and outcome. Suitability for endovascular repair,
based on CTA, was evaluated according to guidelines for
elective EVAR, including proximal neck length of at 15
mm, neck diameter 32 mm with 90° angulation and
50% of circumferential thrombus and calcification. A
conical-shaped neck toward the aneurysm was considered
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of other anatomic contraindications. Access vessels had to
be 6 mm without severe iliac tortuosity to accommodate
the introducer sheaths.
Patients and study design. Inclusion criteria for the
main analyses were rAAA, availability of a preoperative
CTA scan, and suitability for EVAR onCTA scan according
to the experts. The primary comparison of this prospective
controlled study concerned consecutive patients with an
rAAA on preoperative CTA who were considered suitable
for EVAR. EVAR-suitable patients who received rEVAR
were compared with EVAR-suitable patients who received
open surgery.
Data analysis. Statistical analyses were performed
with SPSS 15.0 software (SPSS Inc, Chicago, Ill). Patient
characteristics, clinical outcomes, and follow-up were com-
pared in patients with an rAAA undergoing rEVAR vs
conventional open repair using the 2 test or Fisher’s exact
test, t test, and two-sided Mann-Whitney U test ( 
0.05). Categoric variables are presented as frequency with
percentages. Nominal variables are expressed as mean 
standard deviation (SD) for a normal distribution and for a
skewed distribution in terms of median and interquartile
range (IQR). Values of P .05 were considered statistically
significant.
RESULTS
Population. Between April 2002 and March 2008,
Fig 1. Clinical flow chart. CTA, Computed tomography angiog-
raphy; rAAA, ruptured abdominal aortic aneurysm; rEVAR, en-
dovascular repair of ruptured aneurysm; US, ultrasound imaging;
VS, vascular surgeon.132 patients had a suspected rAAA. CTA was not per-formed in 28 patients (21%): 6 were deemed unfit for any
treatment, in 7 the CTA scanner was not instantly available
30 minutes after presentation, and in 1 the rAAA was
revealed during surgery because preoperative ultrasound
imaging did not show an AAA. Preoperative CTA scanning
was not performed in the other 14 patients due to protocol
violation by a non-rEVAR-vs, because CTA scanning did
not influence treatment selection (rEVAR or open repair)
when a non-rEVAR-vs was on call. A preoperative CTA scan
was performed in 104 patients, of which 58 rAAAs were
considered EVAR-suitable according to the external experts
(55.8% suitability rate). Of 46 patients who were considered
unsuitable, 33 (72%)had inadequate neck length, 5 (11%)had
a neck diameter 32 mm, 8 (17%) had severe neck angula-
tion, and 9 (20%) had unsuitable iliac access. In patients with
an EVAR-suitable rAAA, mean age was 73  8 years, and
93.1% were male. Baseline characteristics for both treatment
groups were comparable (Table I).
Treatment. The rEVAR-vs was on call in 25 of the 58
EVAR-suitable rAAA patients, and they underwent rEVAR
(group 1: mean age, 72.2 8.2 years; Fig 2). All 25 patients
who were considered suitable for EVAR by the rEVAR-vs
were also considered suitable by the experts. None of the
EVAR-suitable patients according to the experts, who pre-
sented during the time that the rEVAR-vs was on call, under-
went open repair. Anesthesia was local in 12 (48.0%), spinal in
5 (20.0%), and general in 8 (32.0%) patients. A Talent bifur-
cated endograft was placed in 9 patients (36.0%) and a Talent
aortouniiliac endograft in 16 patients (64.0%),mainly because
of the later introduction of the bifurcated graft.
Open surgery was performed in 33 of the 58 EVAR-
suitable rAAA patients (group 2; mean age, 74.3  7.1
years; Fig 2). All 33 patients received general anesthesia.
Table I. Baseline characteristics
rEVAR Open surgery
Variable n  25 n  33 P value
Age, mean (SD) y 72.2 (8.2) 74.3 (7.1) .312
Male, No. (%) 22/25 (88.0) 32/33 (97.0) .305
BMI, mean (SD) kg/m2 27.5 (5.5) 25.3 (2.1) .416
Cardiovascular
comorbidity, No. (%) 16/25 (64.0) 24/33 (72.7) .477
Pulmonary comorbidity,
No. (%) 7/25 (28.0) 6/33 (18.2) .375
Renal dysfunction,
No. (%)a 10/24 (41.7) 9/33 (27.3) .255
Diabetes mellitus,
No. (%) 3/25 (12.0) 4/33 (12.1) .99
AAA diameter, mean
(SD) mm 70.8 (16.7) 70.4 (17.6) .932
SBP 100 mm Hg,
No. (%) 9/16 (56.3) 13/24 (54.2) .897
Heart rate, mean (SD),
beats/min 93.0 (21.8) 92.9 (22.1) .995
AAA, Abdominal aortic aneurysm; BMI, body mass index; rEVAR, endo-
vascular repair of ruptured aneurysm; SBP, systolic blood pressure; SD,
standard deviation.
aDefined as a serum creatinine level 140 mol/L.No patients needed suprarenal aortic clamping because
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suitable for rEVAR. A tube graft was used in 28 patients
(84.8%), and a bifurcated prosthesis was used in 5 (15.2%).
Mortality. Outcomes are presented in Table II. The
30-day mortality rate after rEVAR and conventional open
surgery was 20.0% (5 of 25) and 45.5% (15 of 33), respec-
tively, accounting for a difference in mortality of 25.5%
(95% CI, 0.8%-43.6%; P  .04). Three patients in the
rEVAR group died of progressive cardiac failure, one died
of a septic state with multiorgan failure, and one died of
extensive ischemia of the sigmoid colon, for which no
further treatment was instigated.
The causes of death for the patients in the open surgery
group were cardiac arrest in 6, infectious complications in
4, ongoing bleeding resulting in multiorgan failure in 3,
abdominal compartment syndrome in 1, and respiratory
failure in 1. After 6 months of follow-up, the mortality rate
remained 28.0% after rEVAR and 54.5% after open surgery,
with a difference of 26.5% (95% CI, 0.8%-47.6%; P .04).
Complications. Follow-up varied from 6 months to 6
years. Six patients in both treatment groups needed a
reintervention, with a reintervention rate of 24.0% after
rEVAR and 18.2% after open surgery, which was not sta-
tistically significant (P  .59). Reinterventions in the
rEVAR group were performed for endoleak in 3, endograft
infection needing replacement by a rifampicin-soaked bi-
furcated prosthesis in 1, endograft obstruction in 1, and
ischemia of the sigmoid colon in 1.
Reinterventions after open repair of the rAAA were
performed for intra-abdominal bleeding in 2, ischemic
colon in 1, anastomotic aneurysm with an aortoenteric
fistula in 1, and increasing renal dysfunction needing a
dialysis catheter in 1. One patient required two reinterven-
Fig 2. Study flow chart. CTA, Computed tomography
endovascular repair of ruptured aneurysm. *Assessmen
experienced reviewers.tions for intra-abdominal bleeding and an ischemic colon.Overall complication rates were similar: 56.0% after
endovascular repair and 63.6% after open repair (P  .56).
No statistical significance was found between the treatment
groups for deployment-related or procedure-related com-
plications, implant-related complications, and systemic
complications.
In six patients (24.0%) treated with endovascular re-
pair, an endoleak was detected during follow-up, consisting
of a type II endoleak in five (20.0%) and a type I endoleak
for which an extension was placed in one (4.0%).
Median postoperative hospital length of stay was 9.5
days (IQR, 5.0-20.5 days) in rEVAR patients, a significant
reduction compared with 17.0 days (IQR, 9.5-28.0; P 
.03) in the open surgery patients.
Additional findings. Of the 46 patients (Fig 2) who
were not EVAR suitable on the preoperative CTA scan,
30-day and 6-month mortality rates were 47.8% (n  22)
and 58.7% (n  27), respectively. Of the 28 patients who
had no preoperative CTA scan, 30-day and 6-month mor-
tality rates were 50.0% (n  14) and 71.4% (n  20),
respectively.
DISCUSSION
We found rEVAR had a reduced 30-day mortality
compared with open repair that remained for 6 months
after surgery in patients with an rAAA who underwent
preoperative CTA scanning and who were all anatomically
suitable for rEVAR. The mortality rate among the EVAR-
suitable patients treated with open surgery was similar to
the rate in patients who were anatomically unsuitable for
EVAR or in patients without a preoperative CTA scan.
Open surgery and rEVAR both showed early mortality
rates corresponding with the literature.13-17,19,20,24-35
graphy; EVAR, endovascular aneurysm repair; rEVAR,
EVAR suitability in retrospect by two independent,angio
t onMost of these studies, however, did not report patient
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tion to treat all patients presenting with an rAAA, regardless
of their comorbidity and hemodynamic stability. Further-
more, those studies had higher potential for selection bias,
because patients who were hemodynamically stable enough
to undergo preoperative imaging and who had a potentially
more favorable anatomic configuration were assigned to
the EVAR group. Two Dutch studies attempted to com-
pare rEVAR with open repair more adequately, one by
focusing on hemodynamically stable patients20 and the
Table II. Intraoperative, 30-day, and 6-month mortality,
complications, reinterventions, and admissions
rEVAR Open surgery
n  25 n  33
Variable No. (%) No. (%) P value
Intraoperative mortality 1 (4.0) 2 (6.1) .99
30-day mortality 5 (20.0) 15 (45.5) .043
6-month mortality 7 (28.0) 18 (54.5) .043
Overall complication ratea 14 (56.0) 21 (63.6) .556
Requiring surgical
intervention 6 (24.0) 6 (18.2) .588
Deployment/procedure-
relateda 7 (28.0) 11 (33.3) .664
Extensive periop
bleeding 2 (8,0) 8 (24.2) .163
Aortic dissection 0 (0) 0 (0) —
Arterial perforation or
rupture 1 (4.0) 2 (6.1) .99
Peripheral embolization 0 (0) 0 (0) —
False aneurysm 0 (0) 0 (0) —
Fever of unknown
origin (6 days
postop) 3 (12.0) 2 (6.1) .643
Access site complication
Hematoma 1 (4.0) 0 (0) .431
Lymphocele,
lymphorrhea of
lymphedema 0 (0) 0 (0) —
Infection 3 (12.0) 0 (0) .075
Implant-related
complicationsa 4 (16.0) 5 (15.2) .99
Anastomotic aneurysm 0 (0) 1 (3.0) .99
Graft migration 0 (0) 0 (0) —
Graft infection 1 (4.0) 0 (0) .431
Postoperative graft limb
obstruction 1 (4.0) 1 (3.0) .99
Buttock/leg
claudication/ischemia 1 (4.0) 0 (0) .431
Leaking prosthesis 1 (4.0) 3 (9.1) .627
Systemic complicationsa 7 (28.0) 15 (45.5) .175
Cardiac 3 (12.0) 5 (15.2) .99
Pulmonary 2 (8.0) 5 (15.2) 0.687
Renal insufficiency 0 (0) 1 (3.0) .99
Bowel ischemia 2 (8.0) 3 (9.1) .99
Sepsis 1 (4.0) 3 (9.1) .627
Abdominal
compartment
syndrome 0 (0) 1 (3.0) .99
Postop days in hospitalb 9.5 (5.0-20.5) 17 (9.5-28.0) .032
aNumber of patients with one or more complications.
bData are presented as median (interquartile range).other by relying on an intention-to-treat by EVAR proto-col.32 However, the potential for selection bias was still
present despite these methodologic adjustments.
Our study was based on the fact that only one of the
three vascular surgeons in the Atrium Medical Center per-
formed EVAR in patients with an rAAA. Furthermore, all
patients underwent preoperative CTA as part of a uniform
protocol in our emergency department. However, patients
who were considered EVAR-suitable could only be treated
by EVAR if the rEVAR-vs was on call. Suitability for EVAR
was retrospectively determined (confirmed for the rEVAR-
treated group) in all patients by experienced, external,
blinded experts.
Although this study is not randomized, selection bias
regarding anatomic or hemodynamic criteria in the pre-
sented setup is highly unlikely (pseudorandomization).
Moreover, all outcomes were recorded prospectively.
Therefore, the present study provides a fair comparison
between EVAR and open repair.
Study limitations. No CTA was performed in 28
patients (21%), and they could not be evaluated for EVAR
suitability. Furthermore, suitability for EVAR was assessed
in retrospect based on anatomic criteria, whereas EVAR
suitability in daily practice is also based on logistic consid-
erations. Furthermore, this study is limited to one nonaca-
demic teaching hospital, so the individual experiences of
the three involved surgeons could be of influence.
Future need of a randomized controlled trial. Be-
cause of thementioned limitations of this study, results from a
randomized controlled trial comparing rEVAR with open
surgery in patients with an rAAA are needed.However, a pilot
study showed that it is challenging to perform such a random-
ized study.22 Problems include obtaining informed consent in
hemodynamically unstable patients, inclusion of patients un-
suitable for either open surgery or EVAR, instant accessibility
of aCT scanner at all times, permanent availability of a vascular
surgeon who is capable of performing emergency EVAR,
permanent availability of a vascular team dedicated to EVAR,
availability of an OR that is adequately equipped to perform
EVAR, and availability of a variety of off-the-shelf stent
grafts.22,36,37 Yet because of its relative noninvasiveness, en-
dovascular repair is gradually more performed, and data on its
effectiveness in comparison to the conventional surgical ap-
proach are much needed.38
CONCLUSION
The present study showed an absolute 30-day and
6-month mortality reduction of 25.5% and 26.5%, respec-
tively, of rEVAR over open surgery in EVAR-suitable patients
who underwent preoperative CTA scanning. rEVAR is ac-
companied with a significant reduction in postoperative hos-
pital length of stay compared with open repair. Complication
rates and reintervention rates did not differ significantly. These
data strongly suggest that endovascular repair is a valuable
treatment option for EVAR-suitable patients with an rAAA.
We would like to express our gratitude to Jeroen van
den Akker and Toon van der Krieken for assessing all CTA
scans on EVAR-suitability.
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